The road to commercializing cell and gene therapies has been long, with many highs and lows along the way. However, the last few years have seen strong market growth and a very crowded pipeline. In this episode of our Inside Global Pharma podcast, ZS’s Jennifer Curtis and Sankalp Sethi discuss ongoing challenges and what it will take to successfully launch and commercialize these cutting-edge therapies in the U.S. and abroad.
Add insights to your inbox
We’ll send you content you’ll want to read – and put to use.
